The effect of botulinum toxin injections on gait control in spastic stroke patients presenting with a stiff-knee gait

Gait and Posture

Volumn 30, Issue 2, 2009, Pages 168-172

  Bleyenheuft, Corinne ^a   Cockx, Sophie ^b   Caty, Gilles ^b   Stoquart, Gaëtan ^b   Lejeune, Thierry ^b   Detrembleur, Christine ^b  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Botulinum toxin; Gait; Stroke

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GAIT DISORDER; HEMIPARESIS; HUMAN; JOINT STIFFNESS; KINEMATICS; KNEE; MALE; MOTOR CONTROL; PHYSIOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; SPASTICITY; STROKE; WALKING SPEED;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-DYSKINESIA AGENTS; BIOMECHANICS; BOTULINUM TOXIN TYPE A; FEMALE; GAIT; GAIT DISORDERS, NEUROLOGIC; HUMANS; MALE; MIDDLE AGED; MUSCLE SPASTICITY; PARESIS; STROKE;

EID: 67649378623     PISSN: 09666362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gaitpost.2009.04.003     Document Type: Article

References (24)

1. Pittock S.J., Moore A.P., Hardiman O., Ehler E., Kovac M., Bojakowski J., et al. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke. Cerebrovasc Dis 15 4 (2003) 289-300
2. Mancini F., Sandrini G., Moglia A., Nappi G., and Pacchetti C. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot. Neurol Sci 26 April (1) (2005) 26-31
3. Francisco G.E. Botulinum toxin for post-stroke spastic hypertonia: a review of its efficacy and application in clinical practice. Ann Acad Med Singapore 36 January (1) (2007) 22-30
4. Stoquart G.G., Detrembleur C., Palumbo S., Deltombe T., and Lejeune T.M. Effect of botulinum toxin injection in the rectus femoris on stiff-knee gait in people with stroke: a prospective observational study. Arch Phys Med Rehabil 89 January (1) (2008) 56-61
5. Caty G.D., Detrembleur C., Bleyenheuft C., Deltombe T., and Lejeune T.M. Effect of simultaneous botulinum toxin injections into several muscles on impairment, activity, participation, and quality of life among stroke patients presenting with a stiff knee gait. Stroke 39 October (10) (2008) 2803-2808
6. Gracies J.M. Physiological effects of botulinum toxin in spasticity. Mov Disord 19 March (suppl. 8) (2004) S120-S128
7. Borghese N.A., Bianchi L., and Lacquaniti F. Kinematic determinants of human locomotion. J Physiol 494 August (Pt 3) (1996) 863-879
8. Cheron G., Bouillot E., Dan B., Bengoetxea A., Draye J.P., and Lacquaniti F. Development of a kinematic coordination pattern in toddler locomotion: planar covariation. Exp Brain Res 137 April (3-4) (2001) 455-466
9. Lacquaniti F., Grasso R., and Zago M. Motor patterns in walking. News Physiol Sci 14 August (1999) 168-174
10. Grasso R., Bianchi L., and Lacquaniti F. Motor patterns for human gait: backward versus forward locomotion. J Neurophysiol 80 October (4) (1998) 1868-1885
11. Courtine G., and Schieppati M. Tuning of a basic coordination pattern constructs straight-ahead and curved walking in humans. J Neurophysiol 91 April (4) (2004) 1524-1535
12. Lacquaniti F., Le Taillanter M., Lopiano L., and Maioli C. The control of limb geometry in cat posture. J Physiol 426 July (1990) 177-192
13. Stoquart G., Detrembleur C., and Lejeune T. Effect of speed on kinematic, kinetic, electromyographic and energetic reference values during treadmill walking. Neurophysiol Clin 38 April (2) (2008) 105-116
14. Davis R.B.O.S., and Tyburski D. A gait analysis data collection and reduction technique. Hum Mov Sci 10 (1991) 575-587
15. Bianchi L., Angelini D., and Lacquaniti F. Individual characteristics of human walking mechanics. Pflugers Arch 436 August (3) (1998) 343-356
16. Bianchi L., Angelini D., Orani G.P., and Lacquaniti F. Kinematic coordination in human gait: relation to mechanical energy cost. J Neurophysiol 79 April (4) (1998) 2155-2170
17. Grillner S. Control of locomotion in bipeds, tetrapods, and fish. Handbook of physiology. The nervous system. Motor control vol. II (1981), American Physiological Society p. 1179-236 [Chapter 26]
18. Duysens J., and Van de Crommert H.W. Neural control of locomotion: the central pattern generator from cats to humans. Gait Posture 7 March (2) (1998) 131-141
19. Van de Crommert H.W., Mulder T., and Duysens J. Neural control of locomotion: sensory control of the central pattern generator and its relation to treadmill training. Gait Posture 7 May (3) (1998) 251-263
20. Grasso R., Peppe A., Stratta F., Angelini D., Zago M., Stanzione P., et al. Basal ganglia and gait control: apomorphine administration and internal pallidum stimulation in Parkinson's disease. Exp Brain Res 126 May (2) (1999) 139-148
21. Dan B., Bouillot E., Bengoetxea A., and Cheron G. Effect of intrathecal baclofen on gait control in human hereditary spastic paraparesis. Neurosci Lett 280 February (3) (2000) 175-178
22. Patterson S.L., Rodgers M.M., Macko R.F., and Forrester L.W. Effect of treadmill exercise training on spatial and temporal gait parameters in subjects with chronic stroke: a preliminary report. J Rehabil Res Dev 45 2 (2008) 221-228
23. Wiegand H, Wellhoner HH. Proceedings: type A botulinum toxin in cats: neural ascent and action on spinal cord reflexes. Naunyn Schmiedebergs Arch Pharmacol 1974;282(suppl. 282):R106.
24. On A.Y., Kirazli Y., Kismali B., and Aksit R. Mechanisms of action of phenol block and botulinus toxin Type A in relieving spasticity: electrophysiologic investigation and follow-up. Am J Phys Med Rehabil 78 July-August (4) (1999) 344-349